
Dr. Sack Faculty Headshot, Photo: Johns Hopkins Bloomberg School of Public Health
Oral cholera vaccine (OCV) can decrease the severity of a cholera outbreak, reduce rates of disease in endemic settings, and prevent cholera during humanitarian crises and emergencies. Listen to the conversation or read the transcripts below to hear Dr. David Sack, M.D., the Director of the Delivering Oral Vaccine Effectively (DOVE) project and professor of International Health at the Johns Hopkins Bloomberg School of Public Health, discuss the history of OCV and the potential for a single dose vaccine.